Company commits to advancing clinical data for Symplicity™ with the SPYRAL Gemini clinical trial and expansion of the GSR-DEFINE clinical trial GALWAY, Ireland and WASHINGTON, Oct. 28, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today...
SPYRAL HTN-ON MED study shows significant, consistent, long-term blood pressure lowering effect at two years
Seaking AlphaSeeking Alpha / Seaking Alpha 5 hours ago 1 Views
Comments